Skip to main navigation Skip to search Skip to main content

Identification of Cancer Cell Population Dynamics Leveraging the Effect of Pre-Treatment for Drug Schedule Design

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

Abstract

Sequences of different drugs have shown potential to improve treatment strategies for cancer. Typical switched system approaches model the population dynamics of each drug independently, not rigorously considering the effects of pretreatment or drug-drug interactions. In this paper, a general model family incorporating pre-treatment effects and biological domain knowledge is proposed, and a model from this family is identified by using a novel experimental data set of two-drug sequences. Leveraging the data, a simulator for the cell population dynamics under sequences of up to nine drugs is developed and used to empirically evaluate the performance of a set of closed-loop drug scheduling controllers. We used the controllers to identifying promising drug schedules in silico and evaluated them in vitro. The experiments validated the effectiveness of the identified schedules in reducing the number of living cells to less than 10% of the initial. While only treating with certain toxic drugs achieves similar effectiveness, the schedules use toxic drugs for significantly shorter times which likely reduces toxicity to non-cancer cells.

Original languageEnglish (US)
Title of host publication2021 American Control Conference, ACC 2021
PublisherInstitute of Electrical and Electronics Engineers Inc.
Pages1909-1916
Number of pages8
ISBN (Electronic)9781665441971
DOIs
StatePublished - May 25 2021
Event2021 American Control Conference, ACC 2021 - Virtual, Online, United States
Duration: May 25 2021 → May 28 2021

Publication series

NameProceedings of the American Control Conference
Volume2021-May
ISSN (Print)0743-1619

Conference

Conference2021 American Control Conference, ACC 2021
Country/TerritoryUnited States
CityVirtual, Online
Period5/25/21 → 5/28/21

Funding

1M.W., Z.C., and C.J.T. are with the Department of Electrical Engineering and Computer Sciences, University of California, Berkeley, USA. For inquiries contact: [email protected] 2M.T., E.M.L., and R.C.S. are with the Department of Molecular and Medical Genetics, Oregon Health and Science University, USA. 3 M.P.C. is with the Department of Electrical and Computer Engineering, University of Toronto, Toronto, Canada. The authors gratefully acknowledge the support of the NCI CSBC program and the German Academic Exchange Service (DAAD).

Funders
National Institute of Health-National Cancer Institute
Deutscher Akademischer Austauschdienst

    ASJC Scopus subject areas

    • Electrical and Electronic Engineering

    Fingerprint

    Dive into the research topics of 'Identification of Cancer Cell Population Dynamics Leveraging the Effect of Pre-Treatment for Drug Schedule Design'. Together they form a unique fingerprint.

    Cite this